• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据表皮生长因子受体和间变性淋巴瘤激酶基因状态,肺腺癌亚型中[具体基因名称未给出]基因的差异表达。

Differential expression of and genes in lung adenocarcinoma subtypes according to the epidermal growth factor receptor and anaplastic lymphoma kinase gene status.

作者信息

Yu DA-Ping, Dong Yu-Jie, Zhang Hai-Qing, Wang Jing-Hui, Qu Yang, Zhou Li-Juan, Su Dan, Zhang Li-Li, Zhao Dan, Cai Yi-Ran

机构信息

Department of Thoracic Surgery, Beijing Chest Hospital, Capital Medical University, Beijing 101149, P.R. China.

Department of Pathology, Beijing Chest Hospital, Capital Medical University, Beijing 101149, P.R. China.

出版信息

Biomed Rep. 2014 Jul;2(4):481-489. doi: 10.3892/br.2014.261. Epub 2014 Mar 20.

DOI:10.3892/br.2014.261
PMID:24944792
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4051477/
Abstract

Non-small-cell lung cancer (NSCLC) is the most common cause of cancer-related mortality. Adenocarcinoma (AC) is the predominant histological type of NSCLC; however, AC consists of several subtypes. It has not yet been determined whether there is a correlation of CRKL and AXL expression with epidermal growth factor receptor () and anaplastic lymphoma kinase () gene status in lung AC. We assayed exons 18 through 21 of the gene by direct sequencing; rearrangement and the expression of CRKL and AXL were detected by immunostaining. A total of 212 cases of AC were included in this study, diagnosed using the novel classification system established by the International Association for the Study of Lung Cancer, the American Thoracic Society and the European Respiratory Society in 2011, including 69 acinar ACs, 17 lepidic predominant ACs (LPAs), 63 papillary, 14 mucinous, 17 micropapillary and 32 solid ACs. Of the 212 cases, 101 harbored mutations. The most common subtypes carrying delK745-S753 were papillary and acinar ACs. rearrangement was found in 23 cases (11%) of lung ACs. Acinar and solid ACs were the most frequent subtypes with aberrance, particularly in acinar ACs with cribriform structure (4/5 cases, 80%). The expression of CRKL was significantly different among the AC subtypes (P=0.01), with the highest and lowest expression levels of CRKL protein in papillary ACs and LPAs, respectively (P<0.05). AXL expression was also significantly different among the AC subtypes (P=0.002) and was correlated with lymph node infiltration in acinar ACs. ACs with mutations exhibited high levels of AXL protein expression compared to those without mutations (P<0.001). Acinar AC with cribriform structure is a distinct subtype that frequently harbors rearrangement. The activation of may be one of the factors contributing to the invasion of acinar and micropapillary ACs.

摘要

非小细胞肺癌(NSCLC)是癌症相关死亡的最常见原因。腺癌(AC)是NSCLC的主要组织学类型;然而,AC由几种亚型组成。目前尚未确定CRKL和AXL表达与肺AC中表皮生长因子受体()和间变性淋巴瘤激酶()基因状态是否存在相关性。我们通过直接测序检测了该基因的18至21外显子;通过免疫染色检测了CRKL和AXL的重排及表达。本研究共纳入212例AC病例,采用国际肺癌研究协会、美国胸科学会和欧洲呼吸学会于2011年建立的新分类系统进行诊断,包括69例腺泡状AC、17例鳞屑为主型AC(LPA)、63例乳头状、14例黏液性、17例微乳头状和32例实性AC。在212例病例中,101例存在 突变。携带delK745 - S753的最常见亚型是乳头状和腺泡状AC。在23例(11%)肺AC病例中发现了 重排。腺泡状和实性AC是 异常最常见的亚型,尤其是在具有筛状结构的腺泡状AC中(4/5例,80%)。CRKL的表达在AC亚型之间存在显著差异(P = 0.01),CRKL蛋白表达水平在乳头状AC中最高,在LPA中最低(P < 0.05)。AXL表达在AC亚型之间也存在显著差异(P = 0.002),并且与腺泡状AC中的淋巴结浸润相关。与无突变的AC相比,有 突变的AC表现出高水平的AXL蛋白表达(P < 0.001)。具有筛状结构的腺泡状AC是一种独特的亚型,经常存在 重排。 的激活可能是导致腺泡状和微乳头状AC侵袭的因素之一。

相似文献

1
Differential expression of and genes in lung adenocarcinoma subtypes according to the epidermal growth factor receptor and anaplastic lymphoma kinase gene status.根据表皮生长因子受体和间变性淋巴瘤激酶基因状态,肺腺癌亚型中[具体基因名称未给出]基因的差异表达。
Biomed Rep. 2014 Jul;2(4):481-489. doi: 10.3892/br.2014.261. Epub 2014 Mar 20.
2
Expression level of and combined with exon 19 deletion in and status confer differential prognosis of lung adenocarcinoma subtypes.与外显子19缺失相结合的[具体基因1]和[具体基因2]的表达水平以及[具体状态1]和[具体状态2]赋予肺腺癌亚型不同预后。
Oncol Lett. 2016 Nov;12(5):3312-3322. doi: 10.3892/ol.2016.5080. Epub 2016 Sep 2.
3
Association between the histological subtype of lung adenocarcinoma, EGFR/KRAS mutation status and the ALK rearrangement according to the novel IASLC/ATS/ERS classification.根据国际肺癌研究协会(IASLC)/美国胸科学会(ATS)/欧洲呼吸学会(ERS)的新型分类,肺腺癌组织学亚型、表皮生长因子受体(EGFR)/ Kirsten 大鼠肉瘤病毒癌基因(KRAS)突变状态与间变性淋巴瘤激酶(ALK)重排之间的关联。
Oncol Lett. 2016 Apr;11(4):2552-2558. doi: 10.3892/ol.2016.4233. Epub 2016 Feb 17.
4
[Relevance of molecular alterations in histopathologic subtyping of lung adenocarcinoma based on 2011 International Multidisciplinary Lung Adenocarcinoma Classification].基于2011年国际多学科肺腺癌分类的分子改变在肺腺癌组织病理学亚型中的相关性
Zhonghua Bing Li Xue Za Zhi. 2012 Aug;41(8):505-10. doi: 10.3760/cma.j.issn.0529-5807.2012.08.001.
5
High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.韩国男性吸烟肺腺癌患者中 EGFR 突变的高发率:与组织学亚型、EGFR/TTF-1 表达及临床特征的相关性,无肿瘤内异质性。
J Thorac Oncol. 2012 Feb;7(2):323-30. doi: 10.1097/JTO.0b013e3182381515.
6
Mutational Profile and New IASLC/ATS/ERS Classification Provide Additional Prognostic Information about Lung Adenocarcinoma: A Study of 125 Patients from Brazil.突变谱与新的国际肺癌研究协会/美国胸科学会/欧洲呼吸学会分类为肺腺癌提供了额外的预后信息:一项对125例巴西患者的研究。
Oncology. 2015;89(3):175-86. doi: 10.1159/000376552. Epub 2015 Apr 1.
7
Preoperative serum carcinoembryonic antigen levels are associated with histologic subtype, EGFR mutations, and ALK fusion in patients with completely resected lung adenocarcinoma.在完全切除的肺腺癌患者中,术前血清癌胚抗原水平与组织学亚型、表皮生长因子受体(EGFR)突变及间变性淋巴瘤激酶(ALK)融合相关。
Onco Targets Ther. 2017 Jul 7;10:3345-3351. doi: 10.2147/OTT.S134452. eCollection 2017.
8
[Clinicopathological features of lung adenocarcinoma harboring anaplastic lymphoma kinase rearrangements].具有间变性淋巴瘤激酶重排的肺腺癌的临床病理特征
Zhonghua Zhong Liu Za Zhi. 2015 Jun;37(6):436-40.
9
Correlation between EML4-ALK, EGFR and clinicopathological features based on IASLC/ATS/ERS classification of lung adenocarcinoma.基于国际肺癌研究协会(IASLC)/美国胸科学会(ATS)/欧洲呼吸学会(ERS)肺癌腺癌分类的EML4-ALK、EGFR与临床病理特征之间的相关性
Medicine (Baltimore). 2018 Jun;97(26):e11116. doi: 10.1097/MD.0000000000011116.
10
Correlation of survival and EGFR mutation with predominant histologic subtype according to the new lung adenocarcinoma classification in stage IB patients.根据新的肺腺癌分类,IB期患者的生存及EGFR突变与主要组织学亚型的相关性。
World J Surg Oncol. 2014 May 19;12:148. doi: 10.1186/1477-7819-12-148.

引用本文的文献

1
Association between the histological subtype of lung adenocarcinoma, EGFR/KRAS mutation status and the ALK rearrangement according to the novel IASLC/ATS/ERS classification.根据国际肺癌研究协会(IASLC)/美国胸科学会(ATS)/欧洲呼吸学会(ERS)的新型分类,肺腺癌组织学亚型、表皮生长因子受体(EGFR)/ Kirsten 大鼠肉瘤病毒癌基因(KRAS)突变状态与间变性淋巴瘤激酶(ALK)重排之间的关联。
Oncol Lett. 2016 Apr;11(4):2552-2558. doi: 10.3892/ol.2016.4233. Epub 2016 Feb 17.
2
Axl as a mediator of cellular growth and survival.Axl作为细胞生长和存活的介质。
Oncotarget. 2014 Oct 15;5(19):8818-52. doi: 10.18632/oncotarget.2422.

本文引用的文献

1
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer.AXL 激酶的激活导致肺癌对 EGFR 靶向治疗产生耐药性。
Nat Genet. 2012 Jul 1;44(8):852-60. doi: 10.1038/ng.2330.
2
Amplification of CRKL induces transformation and epidermal growth factor receptor inhibitor resistance in human non-small cell lung cancers.CRKL 扩增诱导人类非小细胞肺癌的转化和表皮生长因子受体抑制剂耐药性。
Cancer Discov. 2011 Dec;1(7):608-25. doi: 10.1158/2159-8290.CD-11-0046. Epub 2011 Oct 17.
3
Crizotinib for ALK-rearranged non-small cell lung cancer: a new targeted therapy for a new target.克唑替尼治疗间变性淋巴瘤激酶阳性非小细胞肺癌:一个新靶点的新型靶向治疗药物。
Clin Cancer Res. 2012 Jul 15;18(14):3737-42. doi: 10.1158/1078-0432.CCR-11-2393. Epub 2012 Apr 30.
4
The receptor tyrosine kinase Axl is an essential regulator of prostate cancer proliferation and tumor growth and represents a new therapeutic target.受体酪氨酸激酶 Axl 是前列腺癌增殖和肿瘤生长的重要调节因子,是一个新的治疗靶点。
Oncogene. 2013 Feb 7;32(6):689-98. doi: 10.1038/onc.2012.89. Epub 2012 Mar 12.
5
Expression of MET and SOX2 genes in non-small cell lung carcinoma with EGFR mutation.MET 和 SOX2 基因在 EGFR 突变的非小细胞肺癌中的表达。
Oncol Rep. 2011 Oct;26(4):877-85. doi: 10.3892/or.2011.1349. Epub 2011 Jun 15.
6
Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases.肺腺癌 IASLC/ATS/ERS 分类的影响:基于 514 例 I 期病例分析的预后亚组和对进一步修订分期的影响。
Mod Pathol. 2011 May;24(5):653-64. doi: 10.1038/modpathol.2010.232. Epub 2011 Jan 21.
7
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.国际肺癌研究协会/美国胸科学会/欧洲呼吸学会国际多学科肺腺癌分类。
J Thorac Oncol. 2011 Feb;6(2):244-85. doi: 10.1097/JTO.0b013e318206a221.
8
Reciprocal and complementary role of MET amplification and EGFR T790M mutation in acquired resistance to kinase inhibitors in lung cancer.MET 扩增和 EGFR T790M 突变在肺癌获得性激酶抑制剂耐药中的相互作用和互补作用。
Clin Cancer Res. 2010 Nov 15;16(22):5489-98. doi: 10.1158/1078-0432.CCR-10-1371. Epub 2010 Nov 9.
9
Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.间变性淋巴瘤激酶抑制在非小细胞肺癌中的作用。
N Engl J Med. 2010 Oct 28;363(18):1693-703. doi: 10.1056/NEJMoa1006448.
10
The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma.Axl 受体酪氨酸激酶是食管腺癌的不良预后因素和治疗靶点。
Cancer Biol Ther. 2010 Nov 15;10(10):1009-18. doi: 10.4161/cbt.10.10.13248.